surmount-osa trial tirzepatide results for the Treatment of Obstructive Sleep Apnea and Obesity π @NEJM π https://t.co/RKdvTJxd7Y #ADA2024 Surmount-OSA
Description
Bariatric surgery costs $20,000-30,000 with surgical risks and permanent anatomical changes
(verified owner) Verified review - view original Great product
Strive is a 503A pharmacy that partners with prescribers nationwide
Both agents demonstrate favorable effects on cardiovascular risk factors, including blood pressure reduction and lipid profile improvement
Do not take tirzepatide if you have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
